Formation Bio (@formationbio) / X

Formation Bio

184 posts

Formation Bio

@formationbio

AI-native pharma company, bringing new treatments to patients faster and more efficiently.

New York, NY

Joined November 2014

Pinned
Formation Bio
@formationbio
Apr 17
The world has more promising discovered drug candidates than ever. The problem is developing them. We built Formation Bio to fix that, using AI to develop drugs faster and with a higher likelihood of success. Thank you @amyfeldman and @Forbes telling the story of our mission,
This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
From forbes.com
37K
Formation Bio
@formationbio
Sep 26, 2019
Thrilled to announce that @23andMe and TrialSpark are collaborating to reimagine clinical trials and achieve a common end-goal: accelerate the pace, quality, and experience of clinical trials. Learn more and submit your proposal today: trialspark.com/rfp
Formation Bio
@formationbio
Jun 26, 2024
Today we announce our $372MM Series D financing, led by @a16z with major participation from @sanofi, advancing our mission to bring new treatments to patients faster and more efficiently. Read more here!
With a $372M megaround, Formation Bio looks to in-license 10+ drugs
From endpoints.news
2.9K
Formation Bio
@formationbio
Sep 30, 2021
We're super excited to share that TrialSpark has raised a $156M Series C to support our mission to bring new treatments to patients faster and more efficiently.
prnewswire.com
TrialSpark raises $156MM Series C Funding led by Sam Altman and Lachy Groom
/PRNewswire/ -- TrialSpark announced today that it has raised $156MM in Series C funding. Sam Altman and Lachy Groom led the round, with participation from new...
Formation Bio
@formationbio
Dec 18, 2019
Check out @nikillinit of TrialSpark's Strategic Partnerships team w/ @eriktorenberg & @malayhgandhi on a recent episode of @villageglobal's Venture Stories podcast. They talk startup innovation, strategy, & challenges in the healthcare space. Listen here:
Formation Bio
@formationbio
Jun 19, 2020
We’re proud to take one small step in the ongoing, lifelong work of combating racism, intolerance, and injustice in our country by recognizing Juneteenth as an official annual company holiday. blog.trialspark.com/trialspark-hon…
Formation Bio
@formationbio
Nov 15, 2018
There are several thousand known human diseases, yet we only have FDA-approved treatments for about 500 of them. Our CEO Benjamine Liu explains what we at Trialspark are doing to tackle that challenge — and how you can get involved.
Mission and Purpose at TrialSpark
From medium.com
Formation Bio
@formationbio
Jun 16, 2020
TrialSpark is proud to announce the launch of Project Covalence, a platform that will allow sponsors to rapidly launch clinical trials for COVID-19. Learn more: projectcovalence.com
Formation Bio
@formationbio
Jul 21, 2020
Dr. Michael Mina of the Harvard T.H. Chan School of Public Health enrolled 500 patients in a COVID-19 serological surveillance study in just ten days using TrialSpark’s Covalence trial platform. Learn more about our partnership: prnewswire.com/news-releases/…
Formation Bio
@formationbio
May 21, 2024
We are excited to announce our collaboration with @OpenAI & @sanofi to build fine-tuned and custom AI solutions to transform drug development, advancing our mission to bring new treatments to patients faster and more efficiently.
sanofi.com
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build...
15K
Formation Bio
@formationbio
Sep 17, 2019
Pleased to share news about our collaboration @Pfizer. Read more about how we're working together to increase access to #clinicaltrials: prnewswire.com/news-releases/…
Formation Bio
@formationbio
Oct 31, 2019
Join our CEO, @BenjamineYLiu, at the #CNSSummit tomorrow morning to learn more about the work TrialSpark is doing to improve the speed, quality, and innovation of #clinicaltrials.
Formation Bio
@formationbio
Jan 12, 2022
@TrialSpark has licensed sprifermin, an investigational first-in-class disease modifying treatment for osteoarthritis, from @merckgroup. Read more here about the transaction and TrialSpark's mission to bring new treatments to patients faster. prn.to/33vXmN3
Formation Bio
@formationbio
Oct 30, 2018
Our Head of Data, Ilan Man, shares some advice for the aspiring data scientist. Check out our careers page or drop us a comment here if you're interested in joining our Data team.
Learn the Overlaps: Advice for the Aspiring Data Scientist - Locally Optimistic
From locallyoptimistic.com